Jurnal SINTA 1
Molecular Therapeutic Potency of Metformin by Targeting p53-Related Molecules in Mutant p53 Colon Cancer Cell Line
Indonesian Journal of Cancer Chemoprevention · Vol. 7 No. 1 (2016) · hlm. 17–24
- ISSN
- 2355-8989, 2088-0197
- Terbit
- 2016-02-29
- Penerbit
- Indonesian Society for Cancer Chemoprevention
- Bahasa
- eng
Abstrak
Colon cancer is a malignancy in gastrointestinal tract. It causes high mortality rate in global cancer population. However, chemotherapy as its first option therapy is still controversial due to its effectiveness and its adverse effects. Finding supportive and alternative drugs to cure cancer is one of focus in cancer research. A drug which also has anticancer effects is metformin. Metformin is a biguanide antidiabetic which show its potential anticancer benefit in metabolic-related cancers including colon cancer. To investigate anticancer potency of metformin in targeting p53-related molecules. Metformin treatment were divided into 4 groups by 0, 5, 10 and 20 mM concentrations and incubated in 37o C and 5 % CO2 condition for 48 hours. Immunohistochemistry were conducted to asses level of expression of Bax, p21, cyclin D1 and E2F1, respectively. Level of expression were measured by H-SCORE using percentage and intensity calculation. Comparisons of H-SCORE between groups were performed by ANOVA for parametrical data and Kruskal-Wallis for non-parametrical data. Growth inhibition were observed after metformin treatment. Metformin increases Bax expression significantly at all concentrations. p21 expression was also increased after metformin treatment but is not statistically significant. Subsequently, metformin decreases cyclin D1 expression at 10 and 20 mM concentration thus decreased E2F1 expression at 5 and 10 mM concentration. These data suggest that metformin may have potential therapeutic effects in mutant p53 colon cancer cell line by targeting p53-related molecules.Keywords: Colon cancer; p53; Biguanide; Metformin; p53-mutant cell line
Jaringan kolaborasi para penulis
22 penulis · 57 tautan kepenulisan bersama · 9 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Sebelas Maret University
- IPB University
- Politeknik Kesehatan Kemenkes Surakarta
- Universitas Gadjah Mada
- Umeå University
- Afiliasi tidak diketahui
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Budiyanti Wiboworini | Sebelas Maret University | 2 |
| Irma Isnafia Arief | IPB University | 1 |
| Anantha Sena | Sebelas Maret University | 1 |
| Dono Indarto | Sebelas Maret University | 1 |
| Heru Sulastomo | Sebelas Maret University | 1 |
| Syifa Mahmud Syukran Akbar | Sebelas Maret University | 1 |
| Habibie Arifianto | Sebelas Maret University | 1 |
| Niniek Purwaningtyas | Sebelas Maret University | 1 |
| Ahmad Yasa | Sebelas Maret University | 1 |
| Khusnun Alifah | Sebelas Maret University | 1 |
| Rosmauli Jerimia Fitriani | Sebelas Maret University | 1 |
| laila fitriani | Sebelas Maret University | 1 |
| Eti Poncoini Pamungkasari | Afiliasi tidak diketahui | 1 |
| Yodi Mahendradhata | Universitas Gadjah Mada | 1 |
| Yopi Harwinanda Ardesa | Politeknik Kesehatan Kemenkes Surakarta | 1 |
| Nawi Nawi | Umeå University | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.